Medicare Enrolled
Dr. Luke Chen, M.D.
Hematology & Oncology · Huntington Beach, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chen
Dr. Luke Chen is a hematology & oncology specialist in Huntington Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chen performed 57,846 Medicare services across 1,388 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chen received a total of $60,277 from 75 pharmaceutical and/or device companies across 1028 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$60,277 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,846
Medicare services
Top 13% in CA for hematology & oncology
1,388
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,045 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,000 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 8,280 | $18 | $83 |
| Pembrolizumab injection (Keytruda) | 7,600 | $43 | $194 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
6,900 | $17 | $77 |
| Romosozumab injection (Evenity) for osteoporosis | 6,720 | $8 | $35 |
| Anti-nausea injection (aprepitant) | 3,120 | $1 | $6 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,650 | $36 | $159 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
2,575 | $34 | $151 |
| Anti-nausea injection (ondansetron/Zofran) | 852 | $0 | $0 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
750 | $27 | $119 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
716 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
499 | $102 | $481 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
317 | $12 | $81 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
236 | $58 | $269 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
230 | $14 | $93 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
179 | $18 | $88 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
177 | $120 | $606 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $65 | $341 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
100 | $7 | $31 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $148 | $672 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
74 | $31 | $134 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
68 | $1 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
64 | $25 | $134 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
63 | $12 | $69 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
60 | $29 | $220 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
56 | $26 | $147 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
55 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 50 | $176 | $821 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
49 | $1 | $23 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
46 | $2 | $9 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $66 | $289 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
40 | $25 | $109 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
36 | $59 | $295 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
29 | $54 | $341 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
17 | $70 | $306 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $109 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.6% high complexity
48.7% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$60,277
Total received (2018-2024)
Avg $8,611/year across 7 years
Top 10% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,028
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$32,458 (53.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,114 (25.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,704 (21.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22
2023
$84
2022
$213
2021
$8,838
2020
$13,738
2019
$20,405
2018
$16,977
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$9,535
Seattle Genetics, Inc.
$6,859
Genentech USA, Inc.
$5,574
Takeda Pharmaceuticals U.S.A., Inc.
$5,337
TESARO, Inc.
$3,239
Pfizer Inc.
$2,520
Exelixis Inc.
$2,272
Gilead Sciences, Inc.
$2,097
Regeneron Healthcare Solutions, Inc.
$2,007
AbbVie Inc.
$1,681
Merck Sharp & Dohme Corporation
$1,397
Bayer HealthCare Pharmaceuticals Inc.
$1,320
E.R. Squibb & Sons, L.L.C.
$1,316
Amgen Inc.
$1,217
Genentech, Inc.
$1,200
PFIZER INC.
$1,166
Ipsen Biopharmaceuticals, Inc
$1,111
Novartis Pharmaceuticals Corporation
$1,002
Janssen Biotech, Inc.
$986
Seagen Inc.
$921
Incyte Corporation
$742
GENZYME CORPORATION
$654
Celgene Corporation
$627
Lilly USA, LLC
$579
Astellas Pharma US Inc
$444
Pharmacyclics LLC, An AbbVie Company
$309
Puma Biotechnology, Inc.
$276
EMD Serono, Inc.
$270
Eisai Inc.
$266
Dendreon Pharmaceuticals LLC
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Novocure GmbH
$200
GlaxoSmithKline, LLC.
$175
Athenex Pharmaceutical Division, LLC
$175
Foundation Medicine, Inc.
$156
Janssen Pharmaceuticals, Inc
$150
JAZZ PHARMACEUTICALS INC.
$137
ARRAY BIOPHARMA INC
$134
Clovis Oncology, Inc.
$131
MEDIVATION FIELD SOLUTIONS LLC
$127
Aurobindo Pharma USA, Inc.
$122
AbbVie, Inc.
$114
Alexion Pharmaceuticals, Inc.
$112
COMSORT, Inc
$100
Daiichi Sankyo Inc.
$86
Karyopharm Therapeutics Inc.
$83
Kite Pharma, Inc.
$64
Otsuka America Pharmaceutical, Inc.
$63
BeiGene USA, Inc.
$61
Blueprint Medicines Corporation
$55
Dova Pharmaceuticals
$55
Agios Pharmaceuticals, Inc.
$53
Taiho Oncology, Inc.
$46
TerSera Therapeutics LLC
$43
Coherus Biosciences Inc.
$42
Alnylam Pharmaceuticals Inc.
$42
EUSA Pharma (US) LLC
$41
Janssen Scientific Affairs, LLC
$38
Helsinn Therapeutics (U.S.), Inc.
$36
Secura Bio, Inc.
$31
Acrotech Biopharma LLC
$24
Jazz Pharmaceuticals Inc.
$24
Servier Pharmaceuticals LLC
$20
Spectrum Pharmaceuticals Inc.
$19
Heron Therapeutics, Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Mylan Institutional Inc.
$17
EISAI INC.
$16
Sirtex Medical Inc
$16
Shire North American Group Inc
$15
Teva Pharmaceuticals USA, Inc.
$15
INSYS Therapeutics Inc
$15
Myovant Sciences Inc.
$15
Partner Therapeutics, Inc.
$12
Stemline Therapeutics Inc.
$11
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · CUVITRU · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMEND · EMPLICITI · ERBITUX · ERLEADA · EVENITY · Erleada · FARYDAK · FASLODEX · FOLOTYN · FOUNDATIONONE · Farydak · Folotyn · Fulphila · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LEUKINE · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NICOTROL · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ONPATTRO · ONUREG · OPDIVO · ORGOVYX · Onivyde · PADCEV · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · Prolia · REBLOZYL · RUXIENCE · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUSTOL · SUTENT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · Udenyca · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Veozah · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zydelig · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
204
Per 100K population
6.4
County median income
$113,702
Nearest hospital
HUNTINGTON BEACH HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chen is a mixed practice specialist, with above-average Medicare volume (top 13% in CA), with consulting-driven industry engagement in the top 10% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chen experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Chen performed 15,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chen receive payments from pharmaceutical companies?
Yes. Dr. Chen received a total of $60,277 from 75 companies across 1,028 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chen's costs compare to other hematology & oncology specialists in Huntington Beach?
Dr. Chen's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Huntington Beach
Browse hematology & oncology specialists in Huntington Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology